Henrich, Mason
Ha, Pin
Wang, Yuanyuan
Ting, Kang
Stodieck, Louis
Soo, Chia
Adams, John S.
Chun, Rene
Funding for this research was provided by:
Center for the Advancement of Science in Space (GA-2014-154, GA-2014-154)
National Institute of Arthritis and Musculoskeletal and Skin Diseases (R01AR066782, R01AR068835 and R01AR061399, R01AR066782, R01AR068835 and R01AR061399)
Article History
Received: 11 November 2021
Accepted: 5 April 2022
First Online: 31 May 2022
Declarations
:
: All the animal procedures were performed according to the guidelines of the Chancellor’s Animal Research Committee at UCLA (Protocol# 2009-127) as well as the ISS and KSC Institutional Animal Care and Use Committees.
: Not applicable
: K.T. and C.S. are inventors of Nell-1-related patents. They are founders and/or past board members of Bone Biologics Inc./Bone Biologics Corp., which sublicenses Nell-1 patents from the UC Regents. They also hold equity in the company. All other authors have no potential conflicts of interest to disclose.